Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Hulse

Showing results (91-100 of 107) with videos related to

Pageof 11
Sort By:
BMC Psychiatry|February 2, 2020
Stratified analyses of genome wide association study data reveal haplotypes for a candidate gene on chromosome 2 (KIAA1211L) is associated with opioid use in patients of Arabian descentHiba Alblooshi, Habiba Al Safar, Ahmed El Kashef, et al.
Acta Psychiatrica Scandinavica|November 22, 2011
Overnight changes in waking auditory evoked potential amplitude reflect altered sleep homeostasis in major depressionM R Goldstein, D T Plante, B K Hulse, et al.
Psychiatric Genetics|September 28, 2018
Association of CamK2A genetic variants with transition time from occasional to regular heroin use in a sample of heroin-dependent individualsAntonia Eirich, Teresa Biermann, Christian P Müller, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 27, 2019
The impact of completion thyroidectomyR Sawant, K Hulse, S Sohrabi, et al.
Behavioral Sciences (Basel, Switzerland)|November 10, 2022
Long-Term Management of Generalised Anxiety Disorder with Low-Dose Continuous Infusions of Flumazenil: A Case SeriesAlexander T Gallo, Stephen Addis, Vlad Martyn, et al.
Substance Abuse Treatment, Prevention, and Policy|May 15, 2016
The pattern of substance use disorder in the United Arab Emirates in 2015: results of a National Rehabilitation Centre cohort studyHiba Alblooshi, Gary K Hulse, Ahmed El Kashef, et al.
Addiction Biology|September 18, 2003
Blood morphine levels in naltrexone-exposed compared to non-naltrexone-exposed fatal heroin overdosesDiane E Arnold-Reed, Gary K Hulse, Robert C Hansson, et al.
The American Journal of Drug and Alcohol Abuse|September 25, 2007
A comparison of mental health hospital admissions in a cohort of heroin users prior to and after rapid opiate detoxification and oral naltrexone maintenanceD E Arnold-Reed, P O'Neil, C D J Holman, et al.
Toxicology and Industrial Health|October 4, 2012
Characterization of serotonin transporter gene (SLC6A4) polymorphisms and its association with drug dependence in a Jordanian Arab populationLaith Naser Al-Eitan, Saied Ali Jaradat, Wenwen Qin, et al.
Therapeutic Advances in Psychopharmacology|March 20, 2023
The role of flumazenil in generalised anxiety disorder: a pilot naturalistic open-label study with a focus on treatment resistanceAlexander T Gallo, Stephen Addis, Vlad Martyn, et al.
Pageof 11

Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
BMC Psychiatry|February 2, 2020
Stratified analyses of genome wide association study data reveal haplotypes for a candidate gene on chromosome 2 (KIAA1211L) is associated with opioid use in patients of Arabian descentHiba Alblooshi, Habiba Al Safar, Ahmed El Kashef, et al.
Acta Psychiatrica Scandinavica|November 22, 2011
Overnight changes in waking auditory evoked potential amplitude reflect altered sleep homeostasis in major depressionM R Goldstein, D T Plante, B K Hulse, et al.
Psychiatric Genetics|September 28, 2018
Association of CamK2A genetic variants with transition time from occasional to regular heroin use in a sample of heroin-dependent individualsAntonia Eirich, Teresa Biermann, Christian P Müller, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 27, 2019
The impact of completion thyroidectomyR Sawant, K Hulse, S Sohrabi, et al.
Behavioral Sciences (Basel, Switzerland)|November 10, 2022
Long-Term Management of Generalised Anxiety Disorder with Low-Dose Continuous Infusions of Flumazenil: A Case SeriesAlexander T Gallo, Stephen Addis, Vlad Martyn, et al.
Substance Abuse Treatment, Prevention, and Policy|May 15, 2016
The pattern of substance use disorder in the United Arab Emirates in 2015: results of a National Rehabilitation Centre cohort studyHiba Alblooshi, Gary K Hulse, Ahmed El Kashef, et al.
Addiction Biology|September 18, 2003
Blood morphine levels in naltrexone-exposed compared to non-naltrexone-exposed fatal heroin overdosesDiane E Arnold-Reed, Gary K Hulse, Robert C Hansson, et al.
The American Journal of Drug and Alcohol Abuse|September 25, 2007
A comparison of mental health hospital admissions in a cohort of heroin users prior to and after rapid opiate detoxification and oral naltrexone maintenanceD E Arnold-Reed, P O'Neil, C D J Holman, et al.
Toxicology and Industrial Health|October 4, 2012
Characterization of serotonin transporter gene (SLC6A4) polymorphisms and its association with drug dependence in a Jordanian Arab populationLaith Naser Al-Eitan, Saied Ali Jaradat, Wenwen Qin, et al.
Therapeutic Advances in Psychopharmacology|March 20, 2023
The role of flumazenil in generalised anxiety disorder: a pilot naturalistic open-label study with a focus on treatment resistanceAlexander T Gallo, Stephen Addis, Vlad Martyn, et al.
Pageof 11